Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021

被引:0
|
作者
Jun Hao
Chen Li
Junrong Li
Chuangshi Wang
Yang Li
Chen He
Weida Liu
Sidong Li
Ling Zuo
Wen Hui
机构
[1] Peking Union Medical College and Chinese Academy of Medical Sciences,Medical Research and Biometrics Center, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases
[2] Peking Union Medical College,Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences
[3] Fujian Provincial Center for Disease Control and Prevention,Department of Cardiology
[4] The Guangxi Zhuang Autonomous Region Workers’ Hospital,Medical Research Center, Peking Union Medical College Hospital, Peking Union Medical College
[5] Chinese Academy of Medical Sciences,Department of Integrated Care Management Center, West China Hospital
[6] Sichuan University,Department of Science and Technology, West China Hospital
[7] Sichuan University,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:301 / 310
页数:9
相关论文
共 50 条
  • [1] Characteristics and Trends in Clinical Trials of Cardiovascular Drugs in China from 2009 to 2021
    Hao, Jun
    Li, Chen
    Li, Junrong
    Wang, Chuangshi
    Li, Yang
    He, Chen
    Liu, Weida
    Li, Sidong
    Zuo, Ling
    Hui, Wen
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2023, 23 (03) : 301 - 310
  • [2] A Review Of Trends In Cardiovascular Medicine Clinical Trials; 2012-2021
    Rawlley, Bharat
    Bansal, Kannu
    Dayal, Utkarsh
    Julka, Dhawani
    Salooja, Ishita
    Sanchez, Andres Cordova
    Kumar, Sandeep
    Chaudhuri, Debanik
    CIRCULATION RESEARCH, 2023, 133
  • [3] Trends in characteristics of cardiovascular clinical trials 2001-2012
    Butler, Javed
    Tahhan, Ayman Samman
    Georgiopoulou, Vasiliki V.
    Kelkar, Anita
    Lee, Michael
    Khan, Bilal
    Peterson, Eric
    Fonarow, Gregg C.
    Kalogeropoulos, Andreas P.
    Gheorghiade, Mihai
    AMERICAN HEART JOURNAL, 2015, 170 (02) : 263 - U99
  • [4] Characteristics of clinical trials of new oncology drugs approved in China
    Yang, Jing
    Yang, Ji
    Hu, Yuan-Jia
    CANCER, 2024, 130 (05) : 671 - 682
  • [5] The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009–2021
    Chen Li
    Jun Hao
    Yitian Zheng
    Chuangshi Wang
    Jie Yang
    Wenyao Wang
    Kuo Zhang
    Chunli Shao
    Wen Hui
    Jiancheng Wang
    Wei Li
    Yi-Da Tang
    Diabetology & Metabolic Syndrome, 15
  • [6] The changing landscape of drug clinical trials on cardiometabolic diseases in China, 2009-2021
    Li, Chen
    Hao, Jun
    Zheng, Yitian
    Wang, Chuangshi
    Yang, Jie
    Wang, Wenyao
    Zhang, Kuo
    Shao, Chunli
    Hui, Wen
    Wang, Jiancheng
    Li, Wei
    Tang, Yi-Da
    DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [7] Trends in Consent for Clinical Trials in Cardiovascular Disease
    Kerkhoff, Louis A.
    Butler, Javed
    Kelkar, Anita A.
    Shore, Supriya
    Speight, Candace D.
    Wall, Louisa K.
    Dickert, Neal W.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2016, 5 (06):
  • [8] Trend of drug clinical trials in mainland China from 2009 to 2020
    Cao, Yu
    Liao, Lianming
    Liu, Xin
    Zheng, Qingshan
    Xu, Zhongyuan
    Niu, Haitao
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (09) : 1499 - 1507
  • [9] Molecular epidemiological characteristics of Brucella in Guizhou Province, China, from 2009 to 2021
    Tan, Qinqin
    Wang, Yue
    Liu, Ying
    Tao, Zhongfa
    Yu, Chun
    Huang, Yan
    Yang, Xinggui
    Ying, Xia
    Hu, Yong
    Li, Shijun
    FRONTIERS IN MICROBIOLOGY, 2023, 14